Spyre Therapeutics Inc.

SYRE | NASDAQ

Price Alert Chart Builder DCF Calculator

$91.29

-$0.74 (-0.80%)

Sep 22, 2026, 1:31 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	85.72M	89.42M	188.89M	34.86M	15.14M	90.1M
Short-Term Investments	670.81M	513.67M	150.38M	20.85M	77.99M	56.18M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	10K	331K	2.24M	2.68M	1.96M
Receivables	n/a	n/a	n/a	375K	815K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	21.25M	5.39M	2.25M	6.17M	n/a	n/a
Total Current Assets	777.78M	608.47M	341.53M	62.26M	98.89M	149.79M
Property-Plant & Equipment	n/a	n/a	n/a	6.65M	8.36M	9.87M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	10K	331K	8.89M	11.04M	11.83M
Total Assets	777.78M	608.48M	341.86M	71.14M	109.93M	161.62M
Account Payables	8.9M	666K	896K	677K	3.32M	2.25M
Deferred Revenue	n/a	n/a	n/a	517K	2.36M	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	30.94M	31.27M	5.93M	4.92M	4.99M	4.18M
Total Current Liabilities	58.69M	54.06M	31.98M	14.66M	20.14M	16.44M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.86M	36.62M	125.87M	n/a	n/a	214K
Total Long-Term Liabilities	3.86M	36.62M	125.87M	6.18M	5.84M	5.34M
Total Liabilities	62.55M	90.68M	157.84M	20.84M	25.99M	21.79M
Total Debt	n/a	n/a	n/a	4.63M	5.06M	5.45M
Book Value	715.24M	517.8M	184.02M	50.31M	83.94M	139.83M
Book Value Per Share	11.17	11.01	26.68	14.92	31.92	65.50
Common Stock	15K	13K	10K	6K	5K	5K
Retained Earnings	-1.13B	-972.43M	-764.41M	-425.62M	-341.81M	-276.01M
Comprehensive Income	869K	180K	302K	-48K	-20K	11K
Shareholders Equity	715.24M	517.8M	184.02M	50.31M	83.94M	139.83M
Total Investments	670.81M	513.67M	150.38M	20.85M	77.99M	56.18M